Brief: Sartorius Stedim Biotech Says Q1 Revenue At EUR 762 Mln
April 23 (Reuters) - Sartorius Stedim Biotech SA STDM.PA: SARTORIUS STEDIM BIOTECH REPORTS ROBUST FIRST-QUARTER RESULTS FOR FISCAL 2026 Q1 SALES REVENUE AT 762 MILLION EUROS, UP 7.9% IN CONSTANT CURRENCIES Q1 UNDERLYING EBITDA AT 233 MILLION EUROS, MARGIN 30.7%, NET PROFIT 88 MILLION EUROS MANAGEMENT CONFIRMS FULL-YEAR GUIDANCE FOR FISCAL 2026 Source text: ID:nEQbBxw6Ca Further company coverage: STDM.PA (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))